Collegium Pharmaceutical Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Collegium Pharmaceutical Stock Summary

Collegium Pharmaceutical competes with Phibro Animal, ANI Pharmaceuticals, Procaps Group, Amphastar, and Alkermes Plc. Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts. Collegium Pharma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 152 people.

Collegium Pharmaceutical Key Financial Ratios

Collegium Pharmaceutical Key Balance Sheet Accounts

Collegium Pharmaceutical Key Income Statement Accounts

Collegium Pharmaceutical Key Cash Accounts

Collegium Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Collegium Pharmaceutical's current stock value. Our valuation model uses many indicators to compare Collegium Pharmaceutical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Collegium Pharmaceutical competition to find correlations between indicators driving Collegium Pharmaceutical's intrinsic value. More Info.Collegium Pharmaceutical is number one stock in return on equity category among its peers. It is rated second in return on asset category among its peers reporting about  0.23  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Collegium Pharmaceutical is roughly  4.43 . At this time, Collegium Pharmaceutical's Return On Equity is quite stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Collegium Pharmaceutical by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Collegium Pharmaceutical Systematic Risk

Today, most investors in Collegium Pharmaceutical Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Collegium Pharmaceutical's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Collegium Pharmaceutical growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Collegium Pharmaceutical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Collegium Pharmaceutical. We use our internally-developed statistical techniques to arrive at the intrinsic value of Collegium Pharmaceutical based on widely used predictive technical indicators. In general, we focus on analyzing Collegium Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Collegium Pharmaceutical's daily price indicators and compare them against related drivers.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Collegium Pharmaceutical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more information on how to buy Collegium Stock please use our How to buy in Collegium Stock guide.You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Collegium Pharmaceutical. If investors know Collegium will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Collegium Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Collegium Pharmaceutical is measured differently than its book value, which is the value of Collegium that is recorded on the company's balance sheet. Investors also form their own opinion of Collegium Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Collegium Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Collegium Pharmaceutical's market value can be influenced by many factors that don't directly affect Collegium Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Collegium Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Collegium Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Collegium Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.